Related by context. All words. (Click for frequent words.) 53 therapeutic 51 sublingual desensitization tablets 44 GPCR targets 42 psychopharmacologic 42 theraputic 42 anti HAAH antibodies 41 OSTEOPOROSIS Bones N 41 ophthalmology dermatology cardiovascular disease 41 proprietary DuraSite ® 41 mGluR4 mGluR2 mGluR5 40 brain penetrant 40 GPR# agonists 40 immunology oncology 40 Apo2L 40 pharmacotherapeutic 40 Exelixis compounds 40 lung cancer chemoprevention 39 therapeutical 39 therapeutically 39 neuronal nicotinic receptors NNRs 39 HSP# inhibitors 39 neuroactive 38 peptide conjugated 38 therapy 38 CB1 antagonists 38 psychopharmacological 38 transdermal gel 38 promising anticancer 38 blood clot dissolving 38 diagnostic molecular imaging 37 JAK2 inhibitors 37 treating neuropathic pain 37 radionuclide therapy 37 Squalamine 37 MultiStem ® 37 regenerative stem cell 37 therapeutics diagnostics 37 topically delivered 37 immunological diseases 37 neuro protective 37 Incretin mimetics 37 CollaFix TM 37 therapeutic modalities 37 novel peptide 37 cognition enhancing 37 pharmacologically relevant 37 AVI NEUGENE 37 TNF alpha antagonist 37 CB2 receptor 37 peptidic 37 immuno modulatory 37 recombinant therapies 36 AGHD 36 favorable pharmacokinetic 36 immunoregulatory 36 sd rxRNA 36 ophthalmic diseases 36 anti infective therapeutic 36 treatments 36 anti infective treatments 36 vivo potency 36 lipid altering 36 ADME properties 36 therapeutic radiopharmaceuticals 36 multitargeted 36 Pimavanserin 36 Hedgehog agonist 36 Homspera TM 36 blood clot dissolver 36 pharmacogenetic testing 36 Anticalins R 36 NNR Therapeutics 36 antiresorptive 36 Smac mimetics 36 cyclophilin inhibitors 36 PI3K inhibitors 36 TLR8 36 nonviral 36 sodium stibogluconate 35 vitamin D analogs 35 nucleotide analogs 35 reuptake inhibitors 35 pharmacokinetic properties 35 PI3K inhibitor 35 adipiplon 35 CDK inhibitors 35 diagnostic biomarkers 35 efficacious therapies 35 VDAs 35 Anticalins 35 Lauriad 35 opioid antagonists 35 malaria oral rehydration 35 pramlintide metreleptin combination 35 mTOR inhibition 35 molecular biomarkers 35 PDE7 inhibitors 35 anti angiogenic agents 35 therapeutic peptide 35 3p siRNAs 35 neurology immunology 35 Hsp# inhibition 35 therapies 35 rxRNA compounds 35 CB2 receptor selective 35 psychotherapeutic 35 Therapeutic 35 5 HT2C 35 prokinetic 34 ALTROPANE 34 cardiometabolic disorders 34 AVI BioPharma develops 34 therapeutically relevant 34 radioprotective 34 topical formulations 34 GnRH analogues 34 Anticalins ® 34 proteasome inhibitors 34 clinically validated targets 34 pharmacologic treatments 34 therapeutic modality 34 Alequel 34 anticancer therapeutics 34 TRV# [001] 34 nitric oxide donating 34 Pyridorin 34 Trofex 34 potency selectivity 34 Alequel TM 34 pharmacologic therapies 34 allogeneic cell 34 cognitive enhancer 34 oral talactoferrin 34 Nanobodies 34 therapeutics 34 NEUGENE antisense 34 immune modulating 34 tezampanel NGX# 34 rhITF 34 CB2 selective 34 incyclinide 34 BNC# 34 rxRNA ™ compounds 34 anti CD3 antibody 34 Reiki acupuncture 34 antifibrotic 34 morpholino 34 PDE# inhibitors 34 anti neoplastic 34 antimitotic 34 antineoplastic agents 34 Tyrima 34 pharmacological 33 IAP inhibitors 33 biased ligand 33 CanAg 33 chemopreventive agents 33 antibacterial antiviral 33 oxazolidinone 33 Cardium Therapeutics 33 Metallophile ™ Technology 33 wilate ® 33 SARMs 33 biotherapy 33 parasiticides 33 HIV integrase inhibitors 33 Phage Pharmaceuticals 33 anti angiogenic drugs 33 dexanabinol 33 polymer conjugate technology 33 Anticalin 33 trastuzumab Herceptin ® 33 TÎ ² 4 33 recombinant albumin 33 MTP inhibitor 33 Myolimus 33 NP2 Enkephalin 33 orally inhaled migraine 33 JAK2 inhibitor 33 proteins peptides 33 PDE4 inhibitors 33 ganaxolone 33 Clonicel 33 vascular disrupting agents 33 Tß4 33 maximally tolerated lipid lowering 33 ddRNAi 33 ESBA# 33 topical dermatology 33 resolvins 33 antiviral antibacterial 33 Sangamo ZFP technology 33 Cancidas 33 oral antifungal 33 p# inhibitors 33 OxBC 33 Stapled Peptide 33 anti fibrotic 33 ophthalmology dermatology 33 DCCR 33 antitumour 33 antitumour activity 33 therapeutic monoclonal antibody 32 immunostimulants 32 mGluR5 antagonists 32 geldanamycin 32 rxRNA 32 factor TNF 32 antidepressive 32 nonstimulant 32 erythropoietic 32 TLR8 agonist 32 novel immunotherapeutic 32 Prodarsan ® 32 Micromet BiTE 32 anti CD# antibodies 32 recombinant enzyme 32 isoform selective 32 aptamers 32 humanized monoclonal antibodies 32 immunologic diseases 32 chronic neuropathic pain 32 diagnostic prognostic 32 stabilized RNA aptamer 32 PORxin TM 32 pharmacological treatments 32 immunotherapeutics 32 small molecule activators 32 rBChE 32 investigational compounds 32 potent neuroprotective 32 lipid lowering therapies 32 PET tracers 32 neurogenic 32 intranasal delivery 32 antimetabolite 32 OXIGON TM 32 biobetter 32 neuroprotection 32 cannabinor 32 therapeutic interventions 32 immunomodulator 32 HCV protease inhibitors 32 PI3K/mTOR 32 phosphodiesterase inhibitors 32 sodium thiosulfate STS 32 Mipomersen 32 immune modulator 32 preclinical efficacy 32 EGFR HER 32 antirejection 32 JAK inhibitors 32 fatty acid biosynthesis 32 ocular inflammatory 32 monoclonal antibody therapies 32 class mGluR5 inhibitor 32 regenerative therapies 32 KL4 surfactant 32 potent antibacterial 32 GSK3B 32 AMPAKINE 32 EP #R 32 PDE inhibitors 32 oncology 32 chemical entities NCEs 32 anti resorptive 32 Gemzar gemcitabine 32 MMP inhibitors 32 Nanobody ® 32 oxidative stress inducer 31 investigational monoclonal antibody 31 VEGF inhibitors 31 EGFR tyrosine kinase inhibitors 31 Valdoxan 31 LLLT 31 immunomodulatory agents 31 TG# [003] 31 microtubule inhibitor 31 liposomal delivery 31 immunomodulatory 31 beta emitting radioisotope 31 NEUGENE 31 CRLX# 31 Receptors GPCRs 31 pharmacological approaches 31 telomerase activator 31 pharmacological therapies 31 clevidipine 31 Nanobodies ® 31 Dr. Aiping Young 31 pharmacodynamic properties 31 antagomirs 31 photodynamic 31 tPEMF tm 31 uricase 31 novel anticancer 31 recombinant antibodies 31 novel anti infective 31 pharmacologic intervention 31 investigational therapies 31 insulin sensitizing 31 oral immunomodulatory 31 renin inhibition 31 Tarvacin TM 31 siRNA therapeutic 31 interventional therapies 31 allosteric modulators 31 HPV cervical dysplasia 31 tezampanel 31 iron chelation 31 CINOD 31 Anadys anti infective 31 asthma COPD Chronic 31 antifolates 31 Camptothecin 31 prostone 31 protein kinase inhibitors 31 MAXY VII 31 rxRNA TM compounds 31 predictive biomarkers 31 XmAb ® 31 mda 7 31 antibiofilm 31 oligonucleotide therapeutics 31 pharmacotherapies 31 ibudilast 31 pyridostigmine 31 biomarkers 31 Zybrestat 31 cilengitide 31 nonpharmacologic 31 Azedra 31 immune stimulatory 31 M2 subunit 31 Cx# [002] 31 undruggable targets 31 kinase inhibition 31 antisense oligonucleotides 31 neuroprotective properties 31 pharmacologic approaches 31 Chrysalin 31 topical anti infective 31 magnetic resonance angiography MRA 31 echinocandins 31 nociceptive pain 31 pregabalin Lyrica 31 naltrexone hydrochloride 31 neuro inflammatory 31 Bendavia 31 TLR antagonists 30 transmucosal 30 A3 adenosine receptor 30 HepDirect R 30 XP #L 30 preclinically 30 immunotherapeutic approaches 30 adrenal steroid hormones 30 NexACT 30 anticancer agents 30 telomerase inhibitor 30 Hyphanox 30 anticancer therapy 30 MEK inhibitors 30 cyclophilin inhibitor 30 noninfectious uveitis 30 BEMA TM Fentanyl 30 HCV antiviral 30 topical antifungal 30 targeted antifolate 30 angiogenesis inhibition 30 pharmacokinetics pharmacodynamics 30 targeting CD# 30 ZFNs clinical trials 30 NNRs 30 prostaglandin D2 30 Zoraxel 30 interferon alpha IFN 30 cytotoxics 30 immunotherapeutic vaccine 30 acting inhaled anticholinergic 30 KRN# 30 RNAi therapeutic 30 Bioral 30 Pathway Inhibitor 30 Lisofylline 30 neural regeneration 30 Celator 30 adenosine A2A 30 trastuzumab Herceptin 30 RGB # 30 Aganocide ® 30 Ebola SNALP 30 secretory diarrhea 30 SomatoKine 30 Smac mimetic 30 oncology infectious diseases 30 COX Inhibiting Nitric Oxide 30 adenosine receptor 30 GRN# 30 partial agonist 30 FVIIa 30 Cerashield 30 vaccine adjuvant 30 hepatotoxic 30 antigen sparing 30 therapeutic peptides 30 nutlin 30 monoclonal 30 anticancer drugs 30 anticancer treatments 30 PDE# 30 mGluR5 antagonist 30 Adnectin 30 Transdel TM platform 30 Bevasiranib 30 analgesic 30 Vilazodone 30 cardiotoxic 30 rheumatologic 30 long acting bronchodilator 30 BHT DNA 30 potent anticancer 30 Prostacyclin 30 direct thrombin inhibitors 30 antihypertension 30 histone deacetylase HDAC inhibitors 30 selective kinase inhibitors 30 biologic therapeutics 30 CobaCyte 30 indications Cytokinetics 30 hypophosphatasia 30 protein tyrosine phosphatases 30 deacetylase inhibitors 30 radiolabeled monoclonal antibody 30 Therapy 30 potent antiproliferative 30 Levulan ® PDT 30 RNA therapeutics 30 Hemospan 29 ocular diseases 29 signal transduction inhibitors 29 Dual Opioid TM 29 anti infective 29 pharmacogenetics 29 nebulized budesonide 29 Preclinical studies suggest 29 vinca alkaloid 29 EndoTAGTM 1 29 stereotactic radiation 29 MultiStem 29 molecularly targeted 29 Pancreate ™ 29 IMiDs ® 29 antiinfective 29 CINQUIL 29 alkylating 29 anti secretory 29 histone deacetylase inhibitor 29 immunomodulators 29 Aviptadil 29 Nanobody 29 Cytotoxic 29 histone deacetylase inhibitors 29 KineMed 29 Viprovex TM 29 TLR Therapeutics 29 Aurora kinase inhibitors 29 antiarrhythmic 29 oncolytic 29 insulin sensitizers 29 neuroprotective agent 29 betamethasone dipropionate 29 Hsp# inhibitors 29 biologic therapies 29 immunotherapeutic 29 immunomodulation 29 bortezomib Velcade 29 adrenergic regulation 29 radiolabeled TM# 29 protein therapeutics 29 Anti angiogenic 29 COMT inhibitors 29 thalidomide Thalomid 29 siRNA therapeutics 29 Ketotransdel TM 29 theranostic 29 BGC# 29 oncolytic viruses 29 Transdel TM 29 Corgentin 29 oral antiviral 29 biotherapeutics 29 NovaBay Aganocide compounds 29 peptide therapeutics 29 JAK3 inhibitor 29 Virulizin ® 29 BiTE 29 OncoVEX GM CSF 29 pharmacoeconomic 29 Dual Opioid 29 antisense drug 29 Factor VIIa 29 molecularly targeted therapies 29 orally bioavailable 29 ENMD # 29 druggable 29 inflammatory diseases 29 novel immunomodulatory 29 neuroregenerative 29 thrombin inhibitor 29 LNP formulations 29 Romidepsin 29 metabonomics 29 NGX# 29 Biochronomer 29 G Protein Coupled 29 nicotinic acetylcholine receptor 29 prostones 29 cardiovascular metabolic 29 Hedgehog signaling pathway 29 tasimelteon 29 DXL# 29 PDE4 modulators 29 insulin sensitizer 29 bardoxolone methyl 29 therapeutic monoclonal antibodies 29 delafloxacin 29 potentiator 29 SGLT2 inhibitors 29 analgesic effects 29 dAb 29 polymerase inhibitors 28 Perforomist ™ Inhalation Solution 28 GLPG# 28 Interferon beta 28 antihypertensive agents 28 Proleukin ® 28 prokinetic agent 28 mTOR inhibitors 28 HDAC inhibition 28 ATL# [002] 28 XmAb 28 Antiangiogenic 28 monoclonal antibody therapeutics 28 Bruton tyrosine kinase Btk 28 radiotherapeutic 28 Gleevec inhibits 28 Vidaza azacitidine 28 TLR9 agonist 28 ligand TRAIL 28 immune modulation 28 SERMs 28 indibulin 28 nicotinic 28 mimetics 28 CANCIDAS 28 anticoagulant reversing agent 28 OMP #M# 28 recombinant factor VIIa 28 Interferon alpha 28 combinability 28 constipation OIC 28 neurotrophic factors 28 PI3K/Akt pathway inhibitor 28 Milnacipran 28 Spiegelmers ® 28 antidiabetic 28 Cloretazine R 28 ZFP TFs 28 immunomodulating 28 targeted radiotherapeutic 28 serotonin norepinephrine reuptake inhibitor 28 antineoplastic 28 systemic RNAi 28 chemotherapeutic drug 28 epigenetic therapies 28 RNA antagonists 28 systemic RNAi therapeutic 28 GMX# 28 Zolinza 28 anticancer therapies 28 cyclosporin 28 clinical 28 CTLA4 Ig 28 cytotoxic 28 antiangiogenic agents 28 neurotrophic 28 purinergic receptors P#X# 28 anti angiogenic therapies 28 selectively inhibit 28 PDE7 28 chemotherapeutic agents 28 Curaxin 28 fluoropyrimidine 28 Curaxins 28 clinically relevant 28 Selzentry Celsentri 28 Davanat 28 APD# 28 Fleximer R 28 prodrugs 28 PDE4 inhibitor 28 antiinflammatory 28 peptide antigens 28 oral anticancer 28 HSP# inhibitor 28 immunomodulatory effects 28 PI3K delta 28 Alequel ™ 28 cytoprotective 28 engineered RAP peptides 28 efficacy tolerability 28 TriRima 28 iSONEP 28 Panzem R NCD 28 NexACT ® 28 Nanotope 28 IMiDs R 28 antitumor 28 biotherapeutic 28 Eliezer Zomer Ph.D. 28 AMPAKINE compounds 28 recombinant erythropoietin 28 cannabinoid 27 alpha7 27 anti amnesic 27 antiemetic 27 sigma receptors 27 nutritional supplementation 27 velafermin 27 chimeric monoclonal antibody 27 ZFP TF 27 TLR agonists 27 TRPV1 agonist 27 therapeutic antibodies 27 humanised monoclonal antibody 27 hereditary emphysema 27 LHRH antagonists 27 mecamylamine 27 GI motility disorders 27 Excellagen 27 Enkephalin 27 SMIP 27 Combivir Kivexa 27 chronic viral infections 27 COPREXA ™ 27 Onconase 27 Pazopanib 27 thetreatment 27 relapsed leukemia 27 selective adenosine 27 CCX# 27 vaccines oncolytic virus 27 HDL Mimetic Peptide 27 antibody cytokine 27 peptibody 27 CXB# 27 PARP inhibitors 27 immunotoxin 27 miglustat 27 Cloretazine 27 autologous cell 27 Micro RNAs 27 antithrombotic 27 Cogane 27 chemopreventive 27 disease modifying 27 Amphotericin B 27 AKT inhibitor 27 ophthalmology oncology 27 small molecule inhibitors 27 anti thrombotic 27 biomarker 27 small molecule 27 HuLuc# 27 Symadex 27 Aplidin 27 SGLT inhibitors 27 Prodarsan R 27 calcineurin inhibitors 27 pharmacological chaperone 27 MAb 27 acadesine 27 aptamer therapeutics 27 therapeutic antibody 27 stem cell therapies 27 subcutaneous immunoglobulin 27 Adlea TM 27 cancer immunotherapies 27 bioactive 27 pharmacokinetic interactions 27 Pepducin 27 ZFP Therapeutic 27 resorptive 27 iobenguane 27 HQK 27 synthetic anti infective 27 TELINTRA 27 Hyperbaric Oxygen Therapy HBOT 27 p# inhibitor 27 uric acid lowering 27 Panzem 27 antitumoral 27 Resten NG 27 oncology indications 27 U1 Adaptors 27 Nanobodies R 27 Anidulafungin 27 P#X# 27 histone deacetylase 27 mertansine 27 CEQ# 27 immune modulators 27 LT NS# 27 nucleoside analog 27 JAK inhibitor 27 Serdaxin 26 regenerative medicine therapies 26 Intuniv 26 TLR9 agonists 26 renin inhibitors 26 kinase inhibitors 26 Lixivaptan 26 Anavex #-# 26 treat facial wrinkles 26 Campath alemtuzumab 26 recombinant interferon 26 therapeutic proteins 26 selective androgen receptor modulators 26 Abiraterone acetate 26 PEGylation 26 CNS disorders 26 resolvin 26 pharmacologic 26 doxorubicin HCl 26 HDAC inhibitors 26 Aganocide 26 NXL# 26 Ecallantide 26 neural stem cell 26 ToleroMune 26 CCR9 antagonist 26 EndoTAG TM 26 Cardio Vascu Grow 26 synthetic siRNA 26 SYN# 26 ACV1 26 SNT MC# 26 favorable pharmacokinetic profile 26 ALGRX 26 Rasagiline 26 echinocandin 26 HGS# 26 torezolid phosphate 26 #ME# 26 TNF alpha inhibitor 26 Ceflatonin 26 neurodegenerative diseases 26 incretin 26 KemPharm 26 peripherally acting 26 immuno inflammatory 26 cancer therapeutics 26 Noxafil 26 Capesaris 26 herpetic keratitis 26 siRNA delivery 26 antifolate 26 Dalbavancin 26 diabetic neuropathic pain 26 masitinib 26 immune modulatory 26 VR1 26 antibody therapeutics 26 PXD# 26 neuroprotective 26 Factor IX 26 defensin mimetic antibiotic 26 cancer immunotherapy 26 Delta opioid receptor 26 SPRIX ® 26 antiangiogenic 26 pharmacologic agents 26 MP4OX 26 Factor Xa inhibitor 26 monoclonal antibodies 26 DepoVax 26 epothilone 26 chemotherapy hormonal therapy 26 Pertuzumab 26 JAK3 26 autologous cellular therapy 26 integrase inhibitor 26 Tasimelteon 26 microtubule targeting 26 immunotherapies 26 Sphingomab 25 IMC A# 25 imexon 25 Golimumab 25 Archexin 25 oral prodrug 25 molecular chaperone 25 reversing heparin 25 #HT#A 25 RNAi compounds 25 mAb 25 ASONEP 25 Litx 25 NTDDS 25 OvaRex R 25 EGS# 25 Traficet EN 25 antithrombotics 25 erythropoietins 25 synergistic combinations 25 antiviral therapeutics 25 pan HDAC inhibitor 25 Anticalin R 25 receptor antagonists 25 efficacious 25 Blinatumomab 25 cartilage regeneration 25 MoxDuo 25 Angiocept 25 Homspera 25 Cetrorelix 25 refractory APL 25 Sudhir Agrawal D.Phil 25 PEG SN# 25 MGd 25 neuropathic pain 25 reslizumab 25 anticancer 25 proteasome inhibitor 25 pharmacologic stress 25 small molecule thrombopoietin 25 ICA # 25 regenerative medicine 25 antibody therapies 25 Solulin 25 Multiferon ® 25 bexarotene 25 receptor inhibitor 25 AMPAKINE R 25 NanoCrystal technology 25 Imprime PGG 25 Vascular Endothelial Growth 25 enzastaurin 25 TKM ApoB 25 R#/MEM # 25 YONDELIS 25 novel peptides 25 anti leukemic 25 LibiGel ® 25 carbapenem 25 DOS# 25 hormone LHRH antagonist 25 PSN# [002] 25 Epothilones 25 Gleevec resistant 25 vidofludimus 25 tyrosine kinase inhibitor 24 eniluracil 24 nanoviricide 24 anti infectives 24 biologic 24 monoclonal antibody 24 MAXY G# 24 Menerba 24 autoimmune inflammatory 24 nucleoside tide 24 LEX System 24 TARIS 24 preclinical models 24 proprietary transdermal 24 epothilones 24 gene therapy 24 DiLA2 24 CRx 24 crofelemer 24 selective inhibition 24 nicotinic alpha 7 24 Hsp# inhibitor 24 chemotherapeutics 24 belinostat 24 Crofelemer 24 histone methyltransferases HMTs 24 tiapamil 24 Fc fusion proteins 24 Arcalyst 24 obatoclax 24 dexpramipexole 24 erlotinib Tarceva ® 24 pertuzumab 24 SERCA2a 24 Synavive 24 CGEN # 24 GW# [003] 24 PEGylated interferon 24 short interfering RNA 24 REOLYSIN ® 24 Guanilib 24 CG# [003] 24 RhuDex ® 24 liposomal 24 Cethrin 24 pancreatic enzyme replacement 24 melanocortin receptors 24 protein kinase inhibitor 24 DP b# 24 effector function 24 GPCRs 24 chemotherapeutic 24 kidney urologic 23 Carfilzomib 23 azoles 23 Talabostat 23 tranilast 23 PKC# 23 AEGR 23 ProSavin 23 Campath ® 23 biologics 23 Therapies 23 diseases fat malabsorption 23 stem cell therapy 23 systemic antifungal 23 pomalidomide 23 vilazodone 23 PsychoGenics 23 antisense 23 delta isoform 23 Lu AA# 23 ganetespib 23 macrolide antibiotics 23 PEG Interferon lambda 23 quinolone 23 stem cell therapeutics 23 endothelin receptor antagonists 23 REG1 23 small molecule tyrosine 23 PRT# 23 investigational 23 PSN# [001] 23 VEGF Trap 23 INCB# [001] 23 MDS AML 23 immunotherapy 23 IMiDs ® compound 23 vanilloid receptor 22 glucagon receptor 22 MORAb 22 TPI ASM8 22 liposomal formulation 22 ALN TTR# 22 tigecycline 22 Syntonix 22 Rebif ® 22 RNAi 22 Cethrin R 22 vascular disrupting agent 22 HuMax CD4 22 Elesclomol 22 otelixizumab 22 VEGF receptor 22 biologic therapy 22 optimized siRNA 22 TAFA# 22 BAL# [002] 22 anti angiogenic 22 ALN PCS 22 Omacetaxine 22 dermal patch 22 OncoVEX 22 preclinical 22 Oncaspar 22 Exelixis XL# 22 NTx TM -# 21 PLX MS 21 immunosuppressive 21 CYT# potent vascular disrupting 21 IAP inhibitor 21 TREANDA 21 Amplimexon 21 Hedgehog pathway 21 Delcath System 21 Panzem R 21 inflammatory autoimmune 21 LentiVector technology 20 rFVIIIFc 20 Bicifadine 20 Alocrest 20 receptor agonists 19 RNAi therapeutics 19 preclinical studies 19 OXi# 19 Debio 18 vivo